SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Free Report) saw an uptick in trading volume on Monday. Approximately 145,914 shares changed hands during trading, an increase of 46% from the previous session’s volume of 100,158 shares. The stock last traded at $66.16 and had previously closed at $66.09.
SPDR S&P Pharmaceuticals ETF Stock Performance
The company has a 50 day moving average of $69.59 and a 200 day moving average of $62.72. The stock has a market capitalization of $550.69 million, a price-to-earnings ratio of 14.28 and a beta of 0.59.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Turtle Creek Wealth Advisors LLC purchased a new stake in SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at approximately $26,000. Rockefeller Capital Management L.P. lifted its position in shares of SPDR S&P Pharmaceuticals ETF by 3.2% in the fourth quarter. Rockefeller Capital Management L.P. now owns 20,043 shares of the company’s stock valued at $1,123,000 after acquiring an additional 627 shares in the last quarter. Western Wealth Management LLC acquired a new stake in shares of SPDR S&P Pharmaceuticals ETF during the first quarter valued at $34,000. Fifth Third Bancorp purchased a new stake in SPDR S&P Pharmaceuticals ETF during the 1st quarter worth about $39,000. Finally, First Citizens Bank & Trust Co. raised its stake in SPDR S&P Pharmaceuticals ETF by 0.7% in the 1st quarter. First Citizens Bank & Trust Co. now owns 187,397 shares of the company’s stock valued at $10,136,000 after purchasing an additional 1,393 shares during the last quarter.
About SPDR S&P Pharmaceuticals ETF
SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Read More
- Five stocks we like better than SPDR S&P Pharmaceuticals ETF
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
